Contact Information
Company Information
Technologies
Outlook
Amazon AWS
Google Tag Manager
Mobile Friendly
KNIME
AI
Remote
Keywords
pharmaceutical manufacturing
myopia
pediatric myopia
eyedrop formulation
syd-101
low-dose atropine
clinical trial
phase 3 study
myopic progression
fda approved
topical eye drop
ophthalmic co-morbidities
safety & efficacy
children's vision
drug formulation
atropine degradation
patented formulation
comfort & efficacy
drug activity
myopia treatment
early intervention
vision health
progressive myopia
ocular comorbidities
therapeutic options
sydnexis pipeline
chamber for medicinal products
marketing authorization
european medicines agency
healthcare professionals
eye disease in children
clinical research
therapeutics development
global health issue
myopia awareness
ocular health
stability of formulations
once daily treatment
therapeutic innovations
visual impairment
medical efficacy
public health concern
pediatric ophthalmology
myopia management
registered trial
pharmaceutical industry
biopharmaceutical company
myopia epidemic
patient-centric solutions
innovation in eye care
pharmaceuticals
medical
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans